ReviewNAR cancer2024

DNA abasic sites act as rational therapeutic targets to synergize temozolomide response in both MMR-proficient and deficient cancer.

Achyut Bora et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.